Helga Bronner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Helga Bronner has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Bernd Weigle
Eye Health & Research Beyond Borders, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach a.d. Riss, Germany
2 shared publications - Eva Martin
Global Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach a.d. Riss, Germany
2 shared publications - Jakob Dittmer
Boehringer Ingelheim RCV GmbH & Co. KG, 1121 Vienna, Austria
2 shared publications - Julia Sauer
Immunology & Respiratory, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach a.d. Riss, Germany
2 shared publications - Lina Humbeck
Global Medicinal Chemistry, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach a.d. Riss, Germany
2 shared publications - Marc A. Grundl
Global Medicinal Chemistry, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach a.d. Riss, Germany
2 shared publications
Latest Publications
- Open Access
- 14 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (16) , 7279
Identification of a NUAK1/2 Inhibitor as a Macrophage-Polarizing Compound by a Machine Learning-Based Phenotypic Cell Painting Screen
Disease-associated macrophage states contribute to the pathogenesis of numerous inflammatory disorders. While small molecule-mediated macrophage repolarization represents a promising strategy to restore homeostasis, current approaches often rely on predefined molecular markers and may therefore overlook previously unrecognized modulators of macrophage plasticity. To address this limitation, we performed a phenotypic high-content cell painting screen in induced pluripotent stem cell-derived and blood monocyte-derived macrophages. Using our previously established machine learning-based cell painting analysis pipeline, we screened the annotated opnMe and JUMP-CP compound libraries and identified 26 compounds that induced M1- or M2-like polarization phenotypes. Among these hits, we identified WZ4003, an inhibitor of AMPK-related kinases NUAK1 and NUAK2, as novel macrophage-polarizing compound. Combining cell painting feature profiling with functional analyses, we revealed that the NUAK1/2 inhibitor WZ4003 induces a distinct macrophage state characterized by a rounded M1-like morphology, ferroptosis protection, mitochondrial reactive oxygen species increase, antioxidative adaptation, and phagocytosis and efferocytosis impairment. These findings link specific morphological signatures to functional macrophage states. Overall, this study provides a resource of macrophage-polarizing compounds and demonstrates the utility of machine learning-based cell painting for identifying novel modulators of macrophage polarization states.
- 14 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (16) , 7279
Open AccessIdentification of a NUAK1/2 Inhibitor as a Macrophage-Polarizing Compound by a Machine Learning-Based Phenotypic Cell Painting Screen
Disease-associated macrophage states contribute to the pathogenesis of numerous inflammatory disorders. While small molecule-mediated macrophage repolarization represents a promising strategy to restore homeostasis, current approaches often rely on predefined molecular markers and may therefore overlook previously unrecognized modulators of macrophage plasticity. To address this limitation, we performed a phenotypic high-content cell painting screen in induced pluripotent stem cell-derived and blood monocyte-derived macrophages. Using our previously established machine learning-based cell painting analysis pipeline, we screened the annotated opnMe and JUMP-CP compound libraries and identified 26 compounds that induced M1- or M2-like polarization phenotypes. Among these hits, we identified WZ4003, an inhibitor of AMPK-related kinases NUAK1 and NUAK2, as novel macrophage-polarizing compound. Combining cell painting feature profiling with functional analyses, we revealed that the NUAK1/2 inhibitor WZ4003 induces a distinct macrophage state characterized by a rounded M1-like morphology, ferroptosis protection, mitochondrial reactive oxygen species increase, antioxidative adaptation, and phagocytosis and efferocytosis impairment. These findings link specific morphological signatures to functional macrophage states. Overall, this study provides a resource of macrophage-polarizing compounds and demonstrates the utility of machine learning-based cell painting for identifying novel modulators of macrophage polarization states.
- Open Access
- 17 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (22) , 12330
Insights into the Identification of iPSC- and Monocyte-Derived Macrophage-Polarizing Compounds by AI-Fueled Cell Painting Analysis Tools
Macrophage polarization critically contributes to a multitude of human pathologies. Hence, modulating macrophage polarization is a promising approach with enormous therapeutic potential. Macrophages are characterized by a remarkable functional and phenotypic plasticity, with pro-inflammatory (M1) and anti-inflammatory (M2) states at the extremes of a multidimensional polarization spectrum. Cell morphology is a major indicator for macrophage activation, describing M1(-like) (rounded) and M2(-like) (elongated) states by different cell shapes. Here, we introduced cell painting of macrophages to better reflect their multifaceted plasticity and associated phenotypes beyond the rigid dichotomous M1/M2 classification. Using high-content imaging, we established deep learning- and feature-based cell painting image analysis tools to elucidate cellular fingerprints that inform about subtle phenotypes of human blood monocyte-derived and iPSC-derived macrophages that are characterized as screening surrogate. Moreover, we show that cell painting feature profiling is suitable for identifying inter-donor variance to describe the relevance of the morphology feature ‘cell roundness’ and dissect distinct macrophage polarization signatures after stimulation with known biological or small-molecule modulators of macrophage (re-)polarization. Our novel established AI-fueled cell painting analysis tools provide a resource for high-content-based drug screening and candidate profiling, which set the stage for identifying novel modulators for macrophage (re-)polarization in health and disease.
- 17 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (22) , 12330
Open AccessInsights into the Identification of iPSC- and Monocyte-Derived Macrophage-Polarizing Compounds by AI-Fueled Cell Painting Analysis Tools
Macrophage polarization critically contributes to a multitude of human pathologies. Hence, modulating macrophage polarization is a promising approach with enormous therapeutic potential. Macrophages are characterized by a remarkable functional and phenotypic plasticity, with pro-inflammatory (M1) and anti-inflammatory (M2) states at the extremes of a multidimensional polarization spectrum. Cell morphology is a major indicator for macrophage activation, describing M1(-like) (rounded) and M2(-like) (elongated) states by different cell shapes. Here, we introduced cell painting of macrophages to better reflect their multifaceted plasticity and associated phenotypes beyond the rigid dichotomous M1/M2 classification. Using high-content imaging, we established deep learning- and feature-based cell painting image analysis tools to elucidate cellular fingerprints that inform about subtle phenotypes of human blood monocyte-derived and iPSC-derived macrophages that are characterized as screening surrogate. Moreover, we show that cell painting feature profiling is suitable for identifying inter-donor variance to describe the relevance of the morphology feature ‘cell roundness’ and dissect distinct macrophage polarization signatures after stimulation with known biological or small-molecule modulators of macrophage (re-)polarization. Our novel established AI-fueled cell painting analysis tools provide a resource for high-content-based drug screening and candidate profiling, which set the stage for identifying novel modulators for macrophage (re-)polarization in health and disease.